SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-269865
Filing Date
2020-10-15
Accepted
2020-10-15 08:32:55
Documents
12
Period of Report
2020-10-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d40700d8k.htm   iXBRL 8-K 26978
  Complete submission text file 0001193125-20-269865.txt   149875

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA eigr-20201015.xsd EX-101.SCH 3070
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE eigr-20201015_lab.xml EX-101.LAB 18139
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eigr-20201015_pre.xml EX-101.PRE 11408
5 EXTRACTED XBRL INSTANCE DOCUMENT d40700d8k_htm.xml XML 3441
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36183 | Film No.: 201240359
SIC: 2836 Biological Products, (No Diagnostic Substances)